The Hague, the Netherlands – On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to ...
The executive director of the European and Developing Countries Clinical Trials Partnership talks to Linda Banks about partnerships and clinical trial success stories After spending years of his life ...
Funding of more than €80 million for research into the prevention of HIV/AIDS, tuberculosis and malaria in Africa has been approved by the European & Developing Countries Clinical Trials Partnership ...
EDCTP and CEPI Funding Moves IAVI's Lassa fever Vaccine Candidate Into Advanced Clinical Development
NEW YORK & THE HAGUE, Netherlands & OSLO, Norway--(BUSINESS WIRE)--IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the ...
The European & Developing Countries Clinical Trials Partnership (EDCTP) awarded a new grant to the new PAMAfrica research consortium led by Medicines for Malaria Venture (MMV). The consortium will ...
Cape Town, South Africa – On 26th July 2004, the South African Minister of Health, Dr. Mantombazana Tshabalala-Msimang and Minister of Science & Technology, Mr. Mosibudi Mangena officially opened the ...
An African-European partnership on research into some of the most serious diseases affecting the developing world has been renewed with a budget of €683m from the EU. The European & Developing ...
Addis Ababa and The Hague — The African Union (AU) through the African Centres for Disease Control and Prevention (Africa CDC), and the European and Developing Countries Clinical Trials Partnership ...
African countries often host clinical trials that are led by researchers from other continents. But in the last decade, researchers in Africa are increasingly playing a leading role in clinical ...
The European & Developing Countries Clinical Trials Partnership (EDCTP) awarded a new grant to the new PAMAfrica research consortium led by Medicines for Malaria Venture (MMV). The consortium will ...
EDCTP and CEPI Funding Moves IAVI’s Lassa fever Vaccine Candidate Into Advanced Clinical Development
Global consortium of expert partners will generate proof-of-concept data to support product licensure and future access NEW YORK & THE HAGUE, Netherlands & OSLO, Norway–(BUSINESS WIRE)–#EIDs–IAVI has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results